Shandong Qidu Pharmaceutical Co., Ltd. is located in Linzi District, Zibo City, the former capital of the state of Qi, a famous historical and cultural city. There are more than 3800 employees, covering an area of more than 600 mu and a total asset of nearly 3 billion yuan. Qidu Pharmaceutical Co., Ltd. is a comprehensive research-oriented pharmaceutical production enterprise focusing on injections and combining oral preparations and APIs. Its products mainly involve basic infusion, intravenous nutrition, plasma substitutes, anti-infection, anti-tumor, cardiovascular and cerebrovascular, endocrine, pharmaceutical packaging materials and medical consumables, and has more than 170 drug production approval numbers. In the injection business sector, Qidu pharmaceutical has long been committed to the technical research of intravenous infusion and intravenous drug configuration. It has a professional sales team and technical support department. It can provide all kinds and specifications of intravenous drug combination scheme and intravenous drug configuration technical support for all kinds of medical institutions, and provide high-quality products and services for all patients in need of emergency treatment through close cooperation with medical institutions. The company is a key high-tech enterprise of the national torch plan, a backbone enterprise of the national biomedical industry base, a national comprehensive new drug R & D technology platform industrialization demonstration enterprise, a national industrialization and information integration demonstration enterprise, a national contract abiding and trustworthy enterprise and a provincial civilized unit. "Qidu" trademark and "Qidu pharmaceutical" trademark are well-known trademarks in China, and "Bufumai" trademark and "dinuoxin" trademark are famous trademarks in Shandong Province. It has successively passed ISO9001 international quality management system certification, ISO14001 international environmental management system certification and national intellectual property management system certification. It has a post-doctoral scientific research workstation and a post of a distinguished expert of Taishan scholar pharmacy. The company is also the director unit of China Chemical Pharmaceutical Industry Association, the director unit of China Pharmaceutical Packaging Association, the director unit of China Pharmaceutical Engineering Equipment Association, the director unit of China Pharmaceutical Enterprise Management Association and the vice president unit of Shandong Pharmaceutical Industry Association. It is one of the top 100 enterprises in China's pharmaceutical industry. In the coming period, all aspects of the company's work will closely focus on the overall deployment of the group's development strategic plan, adhere to deepening reform and innovation-driven, adhere to strict management and connotation development, adhere to people-oriented and invigorating the enterprise through science and technology, accelerate the transformation from scale increment type to quality benefit type, and continue to move forward towards the grand vision and goal of "a century-old city, an international city and a billion yuan capital", Strive to make new and greater contributions to local economic and social development and the development of Chinese medicine!